Bntx stocks.
Stock Price Forecast. According to 13 stock analysts, the average 12-month stock price forecast for BioNTech SE stock is $148.69, which predicts an increase of 50.45%. The lowest target is $111 and the highest is $216. On average, analysts rate BioNTech SE stock as a buy.
BNTX Stock Analysis: Negative Earnings Growth and Potential Risks in the Biotechnology Industry. On August 28, 2023, BNTX stock opened at $119.67 and experienced a range of $119.48 to $122.17 throughout the day. The trading volume for the day was 25,809, significantly lower than the average volume of 750,081 over the past three months.BNTX Stock Performance on November 6, 2023: Mixed Results and Concerns for Investors. BNTX stock performances on November 6, 2023 were mixed. The stock opened at $93.34, slightly higher than the previous day’s close of $92.49. Throughout the day, the stock’s price fluctuated within a range of $93.33 to $98.34.Plenty of stocks have been left behind and many carry outsize yields of 6% or more—including a total of about 40 in the S&P 500 and S&P MidCap 400 indexes, according to data from S&P Dow Jones ...Jan 24, 2022 · As half of the duo behind one of the world's most widely used and effective COVID-19 vaccines, BioNTech (BNTX 1.37%) is well on its way to enduring stardom in the healthcare sector. Far from ... SIGA Technologies, Inc. (NASDAQ:SIGA) ranks 11th in our list of the most undervalued biotechnology stocks to buy according to hedge funds. Insider Monkey’s proprietary database of 920 hedge ...
BioNTech SE ADR historical stock charts and prices, analyst ratings, financials, and today’s real-time BNTX stock price. ... BioNTech SE ADR BNTX (U.S.: Nasdaq) search. View All companies. 1:00 ...Nov 29, 2023 · BioNTech's stock sinks after disclosing expected charge of up to nearly $1 billion resulting from Pfizer's write offs of COVID products. Shares of BioNTech SE BNTX, -4.89% sank 6.1% toward a 2 1/2-year low in premarket trading Monday, after the Germany-based biotechnology company disclosed that it currently expects to record a charge o...
Still, if you can handle the heat, BNTX could make for a compelling case as one of the stocks to buy for a rebound. Over time, BioNTech can leverage its success with the Covid-19 vaccine for other ...Medical - Biomedical and Genetics. $23.493B. $18.242B. BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany. Stock Name. Country. Market Cap.
BNTX BioNTech SE-ADR. 100.41 1.16 ( 1.17%) Market Closed Delayed Prices By NASDAQ, in USD. Trade. Overview Chart Analysis News Stats.BioNTech SE ADR analyst ratings, historical stock prices, earnings estimates & actuals. BNTX updated stock price target summary. Thomas Lohnes. Introduction. In my last article on BioNTech (NASDAQ:BNTX), I primarily focused on its valuation and suggested it might be a good buy ahead of its Q2 results.Since then, the stock ...The European Patent Office declared a contested mRNA patent owned by Moderna invalid, the office said on Tuesday, handing a win to BioNTech and its partner Pfizer in a patent dispute between the two coronavirus vaccine makers. Moderna said in a statement that it disagreed with the office's decision and would lodge an appeal.
Nov 24, 2023 · The latest BioNTech stock prices, stock quotes, news, and BNTX history to help you invest and trade smarter. ... BioNTech Stock Snapshot. 173.78 Bid. 100.00 Bid Size ...
27 Mar 2023 ... BioNTech #youtube #stockmarket Don't Miss: Valley of Hype: The culture that built Elizabeth Holmes WATCH HERE: https://youtu.be/Sb179GLPNYE ...
How we approach editorial content. See the latest BioNTech SE ADR stock price (BNTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Shares of BioNTech (BNTX-1.01%) were 9.1% lower as of 11:51 a.m. EDT on Thursday. The German biotech didn't report any news, so why did its stock slide? ... But stocks that share common ...What is BioNTech SE (BNTX)'s stock price today? The current price of BNTX is $99.39. The 52 week high of BNTX is $188.99 and 52 week low is $88.00. When is next earnings date of BioNTech SE (BNTX)?BioNTech (NASDAQ:BNTX) stock rose 4.7% after the drugmaker cut its 2023 revenue target on lower demand for the COVID-19 vaccine made with Pfizer (NYSE:PFE) but said the impact from write-downs at ...Cash Amount. Record Date. Pay Date. Jun 2, 2022. $2.111. Jun 3, 2022. Jun 17, 2022. * Dividend amounts are adjusted for stock splits when applicable. Get the latest dividend data for BioNTech SE (BNTX), including dividend history, yield, key dates, growth and other metrics.The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.3. BioNTech. Per its coronavirus vaccine collaboration with Pfizer, BioNTech ( BNTX 1.40%) is the only company on this list that's currently earning revenue as a result of its sales of mRNA ...
Oct 3, 2023 · BNTX’s price/forward earnings is 5.36. Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper ... BNTX stock analysts expected 4.44 billion euros in sales for the year. Germany-based BioNTech noted fewer people are receiving primary vaccinations and population-wide boosting is much lower.BNTX Earnings Date and Information. BioNTech last posted its earnings data on November 6th, 2023. The reported $0.67 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.59) by $1.26. The firm had revenue of $895.30 million for the quarter, compared to analyst estimates of $850.50 million.Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. BNTX | BioNTech SE ADR Stock Price & News - WSJ BioNTech SE ADR (U.S.: Nasdaq) 1 D 5 D 1 M 3 M YTD 1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ...BNTX stock currently hovers slightly below $170, up 45% over the past 12 months. The stock price has declined 24.5% YTD. Shares are trading at 4.9 times forward earnings and 2.5 times trailing sales.
609.75M. -85.76%. Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ... What this means: InvestorsObserver gives Biontech Se ADR (BNTX) an overall rank of 31, which is below average. Biontech Se ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 31 means that 69% of stocks appear more favorable to our system.
The Zacks database contains over 10,000 stocks. All of those stocks are classified into three groups: Sector, M Industry and X Industry. There are 17 Sectors, 60 different M Industries, and 265 X ...BioNTech Free Cash Flow Forecast for 2023 - 2025 - 2030. In the last three years, Free Cash Flow for BioNTech has grown by 5772.67%, going from $-237.10M to $13.45B. In the coming year, analysts are expecting an increase in Free Cash Flow, predicting it will reach $20.35B – an increase of 51.34%. Over the next eight years, experts anticipate ...BNTX: BioNTech SE - Stock Price, Quote and News - CNBC Nevertheless, contrarians might want to consider picking up BNTX. First, it sits among the blue-chip stocks with value based on key financial ratios. First, BNTX trades at a trailing multiple of 3.14.BioNTech Q3 Profit Falls, Trims FY23 Vaccine Revenue Outlook. RTTNews. Nov. 6, 2023, 08:06 AM. (RTTNews) - BioNTech SE (BNTX) Monday announced a sharp fall in third-quarter earnings compared to ...Some of the best international stocks to buy now include Alibaba Group Holding Limited (NYSE: BABA ), Nutrien Ltd. (NYSE: NTR ), and Unilever PLC (NYSE: UL ).BNTX Stock 12 Months Forecast. $132.67. (38.52% Upside) Based on 12 Wall Street analysts offering 12 month price targets for BioNTech SE in the last 3 months. The average price target is $132.67 with a high forecast of $184.00 and a low forecast of $100.00. The average price target represents a 38.52% change from the last price of $95.78.Nov 29, 2023 · Real time BioNTech Se (BNTX) stock price quote, stock graph, news & analysis.
BNTX stock YTD performance (as of 8 Sep 21). Despite the shared success in Comirnaty, only one of them, BioNTech, is the clear winner so far. Its YTD return raced to almost 450% in early August ...
Oct 19, 2021 · BioNTech (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by almost 9.4% over the last week (five trading days) and by about ...
Shares of vaccine maker BioNTech ( BNTX -1.00%) were down 2.8% early Monday afternoon after falling as much as 6.4% earlier in the day. The decline came after the biotech company reported fourth ...BioNTech SE (BNTX) Company Description: BioNTech SE is a Germany-based biotechnology company that develops and manufactures immunotherapies for cancer, infectious diseases, allergies and ...Dec 1, 2023 · BNTX Earnings Date and Information. BioNTech last issued its quarterly earnings results on November 6th, 2023. The reported $0.67 earnings per share for the quarter, topping the consensus estimate of ($0.59) by $1.26. The business earned $895.30 million during the quarter, compared to analyst estimates of $850.50 million. Mar 2, 2022 · Although shares of biotech company BioNTech (BNTX 0.89%) have recently fallen along with most other stocks, the vaccine maker's performance over the past 12 months remains above that of the ... According to 13 analysts, the average rating for BNTX stock is "Buy." The 12-month stock price forecast is $146.46, which is an increase of 47.34% from the latest price.BNTX’s POWR Ratings reflect its promising outlook. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree. The stock has an A grade for Value and a B in Sentiment and Quality.Get the latest BioNTech SE (BNTX) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Nov 15, 2022 · On November 14, 2022, BioNTech SE (NASDAQ:BNTX) stock closed at $160.37 per share. One-month return of BioNTech SE (NASDAQ:BNTX) was 15.42% and its shares lost 35.97% of their value over the last ...
According to the issued ratings of 10 analysts in the last year, the consensus rating for BioNTech stock is Hold based on the current 6 hold ratings and 4 buy ratings for BNTX. The average twelve-month price prediction for BioNTech is $153.69 with a high price target of $260.00 and a low price target of $111.00. The share price of BioNTech SE (BNTX) now. What analysts predict: $142.42. 52-week High/Low: $188.99 / $88. 50/200 Day Moving Average: $101.74 / $113.19. This figure corresponds to the Average Price over the previous 50/200 days. For BioNTech stocks, the 50-day moving average is the resistance level today.Oct 14, 2023 · The €145 analyst price target for BNTX is 89% more than our estimate of fair value. ... Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the ... Instagram:https://instagram. why 529 plans are a bad ideavanguard small cap etfucare vs united healthcaredental plans vs dental insurance The €145 analyst price target for BNTX is 89% more than our estimate of fair value. ... Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the ... rumble app stockepirus stock Real-time Price Updates for Biontech Se ADR (BNTX-Q), along with buy or sell ... Why Pfizer and BioNTech Stocks Zoomed Higher Today. September 29, 2023. Motley ... webull crypto list The company's average rating score is 2.30, and is based on 4 buy ratings, 5 hold ratings, and 1 sell rating. Price Target Upside/Downside. According to ...View the latest BioNTech SE ADR (BNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.